MNKD:
Analysis & Opinions
-
February 12, 2013
MannKind Corporation's (MNKD) loss of 23 cents per share in the fourth quarter of 2012 was wider than the Zacks ...
-
November 15, 2012
MannKind Corporation (MNKD) recently signed a license agreement with Colby Pharmaceutical Company granting the ...
-
November 02, 2012
MannKind Corporation's (MNKD) loss of 22 cents per share in the third quarter of 2012 was narrower than the Zacks ...
-
October 23, 2012
MannKind Corporation (MNKD) recently announced the pricing of its public offering of 40 million shares along with ...
-
October 18, 2012
MannKind Corporation (MNKD) recently announced that it will be looking to offer and sell shares of its common stock ...
-
October 08, 2012
MannKind Corporation (MNKD) recently announced the completion of the patient recruitment process for its phase III ...
-
August 08, 2012
MannKind Corporation (MNKD) reported a loss of 23 cents per share in the second quarter of 2012, narrower than the ...
-
June 02, 2012
Recently, pre-clinical data on MannKind Corporation's (MNKD) IRE1a inhibitor was published in Blood, the official ...
-
May 02, 2012
MannKind Teams Up with Tolero - Analyst Blog
-
July 23, 2011
Sentiment seems to be turning more favorable toward these three stocks, and given new insider buying, shares may be ...
-
July 07, 2011
A lack of institutional ownership should be a warning sign for biotech investors.
-
May 03, 2011
Novo Nordisk is one of the best pharmaceutical companies in the world - and it's priced accordingly.
-
February 18, 2011
Let's take a look at a few stocks that have recently entered oversold territory because these could be candidates ...
-
January 31, 2011
There's little growth to excite pharma investors, but there is more value here than some realize.
-
January 20, 2011
MNKD got another FDA setback in its attempts to bring inhaled insulin to the market.
-
December 15, 2010
MannKind is a classic high-risk high-reward biotech story.
-
December 03, 2010
Merck is making an exciting bet on a possible diabetes breakthrough.
-
November 09, 2010
2010 has been a rough year in the diabetes space.
-
August 21, 2009
If a financial officer is buying up stocks, chances are that the company's prognosis is good.
-
December 04, 2008
This biotech's inhaled insulin seems to work, but will it sell?
